Dispersion of repolarisation and the autonomic system - Can we predict Torsade de Pointes?

Cardiovascular Drugs and Therapy

Volumn 16, Issue 2, 2002, Pages 93-99

  Huikuri, Heikki ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Autonomic tone; QT interval

Indexed keywords

ALMOKALANT; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOFETILIDE; ION CHANNEL;

ACCURACY; AUTONOMIC NERVOUS SYSTEM; CONFERENCE PAPER; ELECTROCARDIOGRAPHY; GENE; GENE MUTATION; GENOTYPE; HEART REPOLARIZATION; HUMAN; LONG QT SYNDROME; PREDICTION; PRIORITY JOURNAL; QT INTERVAL; RISK; SYMPATHECTOMY; SYMPTOMATOLOGY; T WAVE; TORSADE DES POINTES; GENETIC PREDISPOSITION; GENETICS; MUTATION; PATHOPHYSIOLOGY; REVIEW;

AUTONOMIC NERVOUS SYSTEM; ELECTROCARDIOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; HUMAN; ION CHANNELS; LONG QT SYNDROME; MUTATION; SUPPORT, NON-U.S. GOV'T; TORSADES DE POINTES; HUMANS;

EID: 0035997517     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015745230609     Document Type: Conference Paper

References (51)

1. Long QT syndromes and torsade de pointes
2. The potential for QT prolongation and pro-arrhythmia by non-antiarrhythmic drugs: Clinical and regulatory implication. Report on a Policy Conference of the European Society of Cardiology
3. Electrophysiological mechanisms of the long QT interval syndromes and torsade de pointes
4. Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome
5. Experimental models of torsade de pointes
6. The long QT syndrome and torsade de pointes
7. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: Time to revise current concepts
8. Early afterdepolarization and arrhythmogenesis
9. Torsade de pointes and early afterderepolarizations
10. Drug-induced torsades de pointes: Role of early afterdepolarizations and dispersion of repolarization
11. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions
12. Ionic mechanisms for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates
13. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings
14. Mode of onset of torsade de pointes in congenital long QT syndrome
15. Arrhythmias in the congenital long QT syndrome: How often is torsade de pointes pause dependent?
16. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs
17. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome
18. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome
19. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report
20. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: Effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes
21. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome
22. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias
23. Face immersion in cold water induces prolongation of the QT interval and T-wave changes in children with nonfamilial long QT syndrome
24. Correlation of genetic etiology with response to beta-adrenergic blockade among symptomatic patients with familial long-QT syndrome
25. Early afterdepolarizations induced by isoproterenolin patients with congenital long QT syndrome
26. Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B
27. Alpha-adrenoceptor stimulation and blockade modulates cesium-induced early afterdepolarizations and ventricular tachyarrhythmias in dogs
28. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects
29. Cardiac interbeat interval dynamics from childhood to senescene: Comparison of conventional and new measures based on fractals and chaos theory
30. Baroreflex sensitivity and the renin angiotensin system genes
31. Nonuniform recovery of excitability in ventricular muscle
32. Measurement of the QT interval and the risk associated with QTc interval prolongation: A review
33. Errors in manual measurement of QT intervals
34. Correction of the QT interval for heart rate: Review of different formulas and the use of Bazett's formula in myocardial infarction
35. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia
36. Prognostic significance of risk stratifiers of mortality including T wave alternans after acute myocardial infarction. Results of a prospective follow-up study
37. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals
38. Measurement, interpretation and clinical potential of QT dispersion
39. QT dispersion as an attribute of T-loop morphology
40. Dispersion of ventricular repolarization in the long QT syndrome
41. Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes
42. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome
43. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone
44. Effects of amiodarone, sematilide, and sotalol on QT dispersion
45. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris
46. Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: A prospective study
47. Recording of monophasic action potentials of the right ventricle in long QT syndromes complicated by severe ventricular arrhythmias
48. Vulnerability to ventricular arrhythmia: Assessment by mapping of body surface potential
49. Evaluation of the spatial aspects of T-wave complexity in the long-QT syndrome
50. QT interval and arrhythmic risk assessment after myocardial infarction
51. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome